Obatala Sciences Products Featured in Genetic Engineering & Biotechnology News NewsDavid BodeNovember 17, 2022
Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner Health NewsDavid BodeOctober 13, 2022Series A, Investment
Obatala Staff to Present at IFATS Conference NewsDavid BodeSeptember 15, 2022Conference, IFATS, Adipose, MPS
GNO Inc. Invites Dr. Frazier to Join Panel During GNOuSummit NewsDavid BodeSeptember 7, 2022Conference
Obatala® CEO Speaks to Students at LSU Health Sciences Center New Orleans NewsDavid BodeJuly 25, 2022